In addition to our ICODA core team members, we were supported by and worked very closely with all of our extended team within Health Data Research (HDR) UK, our convenor.
Health Data Research UK is a registered charity no. 1194431 funded by UK Research and Innovation, the Department of Health and Social Care in England and equivalents in Northern Ireland, Wales and Scotland, and leading medical research charities.
Executive Leadership Team
The Executive Leadership Team (ELT) developed the strategic direction for ICODA and was accountable for the delivery of our core work.
The ELT was overseen by, and accountable to HDR UK and our funders. Its work was also guided by advice from our Advisory Councils on Science and Strategy and on Ethics, and an expert group on Statistics.
The ELT brought together key stakeholders as well as members of our ICODA executive team:
- Andrew Morris (Chair)
Director, Health Data Research UK
- Trudie Lang
Global Research Director at Health Data Research UK, Professor of Global Health Research at the University of Oxford and Head of The Global Health Network
- Steve Kern
Deputy Director, Quantitative Sciences; Global Health – Integrated Development, Bill and Melinda Gates Foundation
- David Sibbald
CEO Aridhia Informatics
- Névine Zariffa
Principle and Founder, NMD Group LLC
- Aziz Sheikh
Professor of Primary Care Research & Development and Director of the Usher Institute, University of Edinburgh
- Neil Postlethwaite
Technical Director, ICODA
- Anne Wozencraft
Director of Partnerships and Strategic operations, ICODA
Scientific & Strategic Advisory Council
The Scientific & Strategic Advisory Council provided high-level advice to help us identify opportunities to tackle the COVID-19 pandemic, to deliver scientific impact and overcome the challenges of data sharing.
Aligned with ICODA’s commitment to transparency, the Scientific and Strategic Advisory Council’s Terms of Reference and meeting summaries are publicly available here.
"We are very fortunate to have the opportunity to design a platform for the global community of health researchers to generate better health outcomes for the world."
Agnes Binagwaho, MD, M(Ped), PhD
Co-Chair of Scientific Advisory Council;
Vice Chancellor, University of Global Health Equity;
Former Minister of Health of Rwanda;
Senior Lecturer on Global Health and Social Medicine, Harvard Medical School
"The Covid-19 pandemic presents our world a powerful opportunity … and responsibility … to share knowledge in real-time. Time must not be wasted because lives and livelihoods hang in the balance. ICODA has been created and dedicated to facilitating Partnership … Progress … that will derive Hope. We are stronger together. Our shared data will supercharge discovery that will save lives."
Martin J. Murphy, DMedSc, PhD, FASCO
Founding Chief Executive Officer, CEO Roundtable on Cancer
Founding CEO of Project Data Sphere, LLC, a non-profit enterprise devoted to cancer clinical trial data-transparency, data-sharing and data-analysis
Prof Agnes Binagwaho
Dr Martin J Murphy
Prof Frank Rockhold
Prof John Danesh
Prof Nicky Mulder
Prof Steve Webb
Prof Trudie Lang
Prof Wang Yu
Prof Liang Wannian
Ethics Advisory Council
The Ethics Advisory Council provided high-level advice on ethics and data governance, helping us to build and demonstrate trustworthiness across all our activities.
- Effy Vayena (Chair)
Chair of Bioethics, at the Swiss Institute of Technology (ETHZ)
- Pamela Andana
Wits University, South Africa
- Claudia Emerson
McMaster University, Canada, Director, Institute on Ethics & Policy for Innovation
- Sharon Kaur
University of Malaysia
- Katherine Littler
Co-Lead, Global Health Ethics & Governance Unit, World Health Organization
- Graeme Laurie,
Professor of Medical Jurisprudence, University of Edinburgh
- Elettra Ronchi
Senior Policy Analyst, OECD
Aligned with ICODA’s commitment to transparency, the Ethics Advisory Council’s Terms of Reference and meeting summaries are publicly available.
The Ethics Advisory Council has provided advice on the development of our Ethics and Governance Framework, and acted as an independent guardian of the Framework.
Statistical Expert Group
The Statistical Expert Group (SEG) promoted and facilitated responsible sharing of data, use of analytical methods and tools, and high quality results to support dissemination of knowledge worldwide.
- Jonas Häggström (chair)
VP Global Health, Cytel
- Frank Rockhold
Professor of Biostatistics and Bioinformatics, Duke Clinical Research Institute
- Amy Racine
Distinguish Scientist, Novartis
- Joan Buenconsejo
Senior Director, Biostatistics, AstraZeneca
- Maia Leskovsky
Associate Professor, University of Cape Town
- Ling Wang
Executive Director Biostatistics, Pfizer
- John Norrie
Chair of Medical Statistics and Trial Methodology, Director, Edinburgh Clinical Trials Unit (ECTU)
- Peter Mensenbrink
Executive Director Biostatistics, Novartis
- Estelle Russek-Cohen
Senior Advisor Office of Biostatistics, CDER
- Robin Mogg
Clinical Biostatistics Leader – Bill & Melinda Gates Medical Research Institute
“There is this underlying tenet that everything we do is based on equality, collaboration, and open access to data and information. So, it was obvious for the Minderoo Foundation to understand the context of this initiative. We were impressed by the partners involved on the funder side and with HDR UK as the convener, so it seemed appropriate to support this Alliance.”
ICODA was convened by Health Data Research UK – the national institute for health data in the UK. It was supported by a grant from the COVID-19 Therapeutics Accelerator, a large-scale initiative initiated by the Bill & Melinda Gates Foundation, Wellcome, Mastercard with additional support from Minderoo Foundation, and other donors to speed the development of and access to therapies for COVID-19. Other funders to the International COVID-19 Alliance included Microsoft, through its AI for Health program:
ICODA provided the opportunity to make a real difference to harness the power of health data to help tackle the COVID-19 pandemic. ICODA was a rapidly-convened initiative and an ambitious and dynamic global programme.
We were a diverse group of experts working together, based on a set of united principles and a “One Institute” approach, a collaborative culture inherited from our convenor, Health Data Research UK.